NYSE:Inari Medical, Inc.
График котировок Inari Medical, Inc.
График NARI предоставлен TradingView
Добавить в список сравнения
Добавить в список отслеживания
Добавить в портфель
Основные параметры
P/E | 593.28 |
---|---|
P/S | 51.11 |
P/BV | 22.21 |
EV/EBITDA | 374.9 |
EBITDA | 0.01 |
Цена ао | 116.4 |
Основные владельцы
Institutions | Объем | Доля, % |
---|---|---|
Public Mutual Berhad | 25000 | 0.05 |
Wells Fargo Funds Management LLC | 702109 | 1.44 |
Delaware Management Company | 606284 | 1.24 |
Macquarie Investment Management Advisers | 72567 | 0.15 |
AllianceBernstein LP. | 82769 | 0.17 |
Brown Advisory LLC | 387547 | 0.8 |
Wells Fargo Asset Management | 529 | 0 |
AllianceBernstein Corporation | 39882 | 0.08 |
Lisanti Capital Growth, LLC | 15550 | 0.03 |
Wells Capital Management Inc. | 117960 | 0.24 |
AH Lisanti Capital Growth LLC | 93346 | 0.19 |
Principal Global Investors, LLC | 270695 | 0.56 |
Driehaus Capital Management (USVI) LLC | 18423 | 0.04 |
Perceptive Advisors LLC | 848500 | 1.74 |
Nationwide Fund Advisors | 146491 | 0.3 |
SunAmerica Asset Management, LLC | 95638 | 0.2 |
Heptagon Capital Limited | 43342 | 0.09 |
Equitable | 168917 | 0.35 |
Baron Capital Management Inc | 89823 | 0.18 |
Wells Fargo Funds Management | 7790 | 0.02 |
Soleus Capital Management, L.P. | 65817 | 0.14 |
SSGA Funds Management Inc | 143636 | 0.29 |
Affinity Investment Advisors, LLC | 440 | 0 |
SEB Investment Management AB | 64790 | 0.13 |
Santander Private Banking Gestión SGIIC | 0 | 0 |
Brown Advisory | 448 | 0 |
Pier Capital, LLC | 55932 | 0.11 |
Содержится в ETF
ETF | Доля, % | Доходность за год, % |
---|---|---|
SPDR S&P Health Care Equipment ETF | 2 | 41.90 |
Похожие компании
Описание Inari Medical, Inc.
Inari Medical, Inc., a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States. It produces ClotTriever for treatment of deep vein thrombosis; and FlowTriever, a thrombectomy system for treatment of pulmonary embolism. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was founded in 2011 and is headquartered in Irvine, California.